Clinical Outcome of Female Non-gastric Gastrointestinal Stromal Tumor

Far Eastern Memorial Hospital

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04256226

Enrollment

Registered

2020-02-05

Start date

2020-02-01

Completion date

2020-03-31

Last updated

2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Stromal Tumor

Brief summary

To elucidate the prognosis of women with non-gastric primary gastrointestinal stromal tumors.

Detailed description

Gastrointestinal stromal tumor (GIST) are mesenchymal tumors arising from gastrointestinal tract, mesentery, or omentum. They took up about 3% of gastrointestinal malignancies. Although rarely, the clinical presentation of non-gastric GIST might mimick ovarian cancer, and would be managed by gynecologists. Therefore, retrospective review of female non-gastric GIST cases will be performed to investigate the clinical outcome of non-gastric GIST. The result of this study might be used as an important reference for gynecologists.

Interventions

PROCEDURETumor excision

Excision of GIST

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to No maximum

Healthy volunteers

Inclusion criteria

* \> 20 years of women. * non-gastric gastrointestinal stromal tumor

Exclusion criteria

* Those without pathological report or surgical record.

Design outcomes

Primary

Measure	Time frame	Description
Overall survival	20 years	The date of surgery to the date of death or last follow-up

Secondary

Measure	Time frame	Description
Recurrence-free survival	20 years	The date of surgery to the date of recurrence or last follow-up

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026